Shaylene McCue

Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial

Robert D. McBane, Charles L. Loprinzi, Tyler Zemla et al. · Journal of Thrombosis and Haemostasis · 2024 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

ST8Sia6 Promotes Tumor Growth in Mice by Inhibiting Immune Responses

David J. Friedman, Sydney B. Crotts, Michael J. Shapiro et al. · Cancer Immunology Research · 2021 · 38 citations · Full text

Medicine, Immunology, Oncology +17

Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers

Jena D. French, Bryan R. Haugen, Francis P. Worden et al. · Clinical Cancer Research · 2024 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Cutting Edge: ST8Sia6-Generated α-2,8-Disialic Acids Mitigate Hyperglycemia in Multiple Low-Dose Streptozotocin–Induced Diabetes

Paul Belmonte, Michael J. Shapiro, Matthew Rajcula et al. · The Journal of Immunology · 2020 · 17 citations · Full text

Life Sciences, Endocrinology, Immunology +17

1917P Pembrolizumab salvage add-on therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC) progressing on lenvatinib: Results of a multicenter phase II International Thyroid Oncology Group Trial

Bryan R. Haugen, Jena D. French, Francis P. Worden et al. · Annals of Oncology · 2020 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +10